Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis.

× No keyword cloud information.

5 in total

Review 1. Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials.

Authors: Ana Boquete-Castro; Gerardo Gómez-Moreno; José Luis Calvo-Guirado; Antonio Aguilar-Salvatierra; Rafael Arcesio Delgado-Ruiz
Journal: Clin Oral Implants Res Date: 2015-02-02 Impact factor: 5.977

2. Dental treatments, tooth extractions, and osteonecrosis of the jaw in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.

Authors: Takefumi Furuya; Shigeru Maeda; Shigeki Momohara; Atsuo Taniguchi; Hisashi Yamanaka
Journal: J Bone Miner Metab Date: 2016-07-02 Impact factor: 2.626

3. Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-α) inhibitors: a systematic review.

Authors: R Sacco; S Shah; R Leeson; V Moraschini; C F de Almeida Barros Mourão; O Akintola; A Lalli
Journal: Br J Oral Maxillofac Surg Date: 2019-10-20 Impact factor: 1.651

4. Antiresorptive agents-related osteonecrosis of the jaw (ARONJ) in rheumatoid arthritis.

Authors: Yuichiro Fujieda; Tatsuya Atsumi
Journal: J Bone Miner Metab Date: 2020-09 Impact factor: 2.626

5. Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors: Tsutomu Takeuchi; Yoshiya Tanaka; Satoshi Soen; Hisashi Yamanaka; Toshiyuki Yoneda; Sakae Tanaka; Takaya Nitta; Naoki Okubo; Harry K Genant; Désirée van der Heijde
Journal: Ann Rheum Dis Date: 2019-04-29 Impact factor: 19.103

5 in total